Annual CFF
$71.86 M
+$71.86 M+100.00%
December 31, 2023
Summary
- As of February 8, 2025, IOBT annual cash flow from financing activities is $71.86 million, with the most recent change of +$71.86 million (+100.00%) on December 31, 2023.
- During the last 3 years, IOBT annual CFF has risen by +$66.76 million (+1308.47%).
- IOBT annual CFF is now -71.59% below its all-time high of $252.95 million, reached on December 31, 2021.
Performance
IOBT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, IOBT quarterly cash flow from financing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, IOBT quarterly CFF has stayed the same.
- IOBT quarterly CFF is now -100.00% below its all-time high of $187.54 million, reached on December 31, 2021.
Performance
IOBT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$10.00 K
-$71.87 M-100.01%
September 30, 2024
Summary
- As of February 8, 2025, IOBT TTM cash flow from financing activities is -$10.00 thousand, with the most recent change of -$71.87 million (-100.01%) on September 30, 2024.
- Over the past year, IOBT TTM CFF has dropped by -$71.87 million (-100.01%).
- IOBT TTM CFF is now -100.00% below its all-time high of $252.95 million, reached on December 31, 2021.
Performance
IOBT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IOBT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | -100.0% |
| 3 y3 years | +1308.5% | 0.0% | -100.0% |
| 5 y5 years | +697.2% | 0.0% | -100.0% |
IOBT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -71.6% | -100.0% | -100.0% | +100.0% | -100.0% | at low |
| 5 y | 5-year | -71.6% | -100.0% | -100.0% | +100.0% | -100.0% | at low |
| alltime | all time | -71.6% | -100.0% | -100.0% | +100.0% | -100.0% | at low |
IO Biotech Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | -$10.00 K(-100.0%) |
| Jun 2024 | - | $0.00(0.0%) | $71.86 M(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) | $71.86 M(0.0%) |
| Dec 2023 | $71.86 M(>+9900.0%) | -$10.00 K(-100.0%) | $71.86 M(-0.0%) |
| Sep 2023 | - | $71.87 M(>+9900.0%) | $71.87 M(>+9900.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(0.0%) | $187.54 M(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $187.54 M(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $187.54 M(-25.9%) |
| Dec 2021 | $252.95 M(+4857.9%) | $187.54 M(>+9900.0%) | $252.95 M(+286.7%) |
| Sep 2021 | - | $0.00(0.0%) | $65.41 M(0.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $65.41 M(0.0%) |
| Mar 2021 | - | $65.41 M | $65.41 M |
| Dec 2020 | $5.10 M(-43.4%) | - | - |
| Dec 2019 | $9.01 M | - | - |
FAQ
- What is IO Biotech annual cash flow from financing activities?
- What is the all time high annual CFF for IO Biotech?
- What is IO Biotech annual CFF year-on-year change?
- What is IO Biotech quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for IO Biotech?
- What is IO Biotech quarterly CFF year-on-year change?
- What is IO Biotech TTM cash flow from financing activities?
- What is the all time high TTM CFF for IO Biotech?
- What is IO Biotech TTM CFF year-on-year change?
What is IO Biotech annual cash flow from financing activities?
The current annual CFF of IOBT is $71.86 M
What is the all time high annual CFF for IO Biotech?
IO Biotech all-time high annual cash flow from financing activities is $252.95 M
What is IO Biotech annual CFF year-on-year change?
Over the past year, IOBT annual cash flow from financing activities has changed by +$71.86 M (+100.00%)
What is IO Biotech quarterly cash flow from financing activities?
The current quarterly CFF of IOBT is $0.00
What is the all time high quarterly CFF for IO Biotech?
IO Biotech all-time high quarterly cash flow from financing activities is $187.54 M
What is IO Biotech quarterly CFF year-on-year change?
Over the past year, IOBT quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is IO Biotech TTM cash flow from financing activities?
The current TTM CFF of IOBT is -$10.00 K
What is the all time high TTM CFF for IO Biotech?
IO Biotech all-time high TTM cash flow from financing activities is $252.95 M
What is IO Biotech TTM CFF year-on-year change?
Over the past year, IOBT TTM cash flow from financing activities has changed by -$71.87 M (-100.01%)